We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » DDMAC ISSUES WARNING LETTER ON VIDEO PROMOTION FOR BEXXAR
DDMAC ISSUES WARNING LETTER ON VIDEO PROMOTION FOR BEXXAR
March 22, 2004
The FDA’s Division of Drug Marketing, Advertising and Communications (DDMAC) has told Corixa to immediately cease distribution of a promotional video for its combination cancer treatment and provide the FDA with a plan of action to correct misleading safety and efficacy claims made in the video.